You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 57 No. 5, May 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (36)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Aging/ Geriatrics
 •Alzheimer Disease
 •Cognitive Disorders
 •Dementias
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Mild Cognitive Impairment or Questionable Dementia?

Arch Neurol. 2000;57:643-644.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

THE BOUNDARY between normal aging and very early Alzheimer disease (AD) is becoming a central focus of research. Much of the work on preventive strategies in AD is oriented toward the development of drugs, such as secretase inhibitors, or immunization techniques to prevent the onset of the disease. This work is predicated on the notion that the distinction between the cognitive changes of aging and very early AD is well delineated. It has become the responsibility of clinical investigators to characterize the transitional state between normal aging and the earliest stages of cognitive impairment.

Recent work on mild cognitive impairment (MCI) draws attention to this distinction between normal aging and very early AD.1 A recent conference on "Current Concepts in Mild Cognitive Impairment" highlighted the heterogeneity of this concept.2 Some controversy exists as to the precise manner in which to characterize these subjects, but the importance of making this distinction . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Reaction Times and Performance Variability in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease
Gorus et al.
J Geriatr Psychiatry Neurol 2008;21:204-218.
ABSTRACT  

Discriminative and predictive power of an informant report in mild cognitive impairment
Isella et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:166-171.
ABSTRACT | FULL TEXT  

Perspectives on Depression, Mild Cognitive Impairment, and Cognitive Decline
Steffens et al.
Arch Gen Psychiatry 2006;63:130-138.
ABSTRACT | FULL TEXT  

Neuropsychosocial Features of Very Mild Alzheimer's Disease (CDR 0.5) and Progression to Dementia in a Community: The Tajiri Project
Meguro et al.
J Geriatr Psychiatry Neurol 2004;17:183-189.
ABSTRACT  

Achieving and Maintaining Cognitive Vitality With Aging
Fillit et al.
Mayo Clin Proc. 2002;77:681-696.
ABSTRACT  

MRI measures of entorhinal cortex vs hippocampus in preclinical AD
Killiany et al.
Neurology 2002;58:1188-1196.
ABSTRACT | FULL TEXT  

Current Concepts in Mild Cognitive Impairment
Petersen et al.
Arch Neurol 2001;58:1985-1992.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.